CRP Gene clinical trials
16 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones you may be eligible for.
- Comparative Effectiveness of Primary Care Providers Trained in Rheumatoid Arthritis Management Versus Rheumatologist Care: A Randomized Controlled Trial
- Leucine in Midlife Depression
- Dopaminergic Therapy for Anhedonia - 2
- Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
- Colchicine in Acutely Decompensated HFREF
- Stem Cell Therapy for Early Alzheimer's Disease
- Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
- Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD
- JAK Signaling in Depression
- Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
- Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
- Inflammation and Depression in People With HIV
- Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
- Anti-Inflammatory Challenge in Schizophrenia
- Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
- JAK Signaling in Depression and Cognition in Male Football Players
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “CRP Gene” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.